UK clinical trials - updated daily from ClinicalTrials.gov
Understand the key differences between prostate cancer and colorectal cancer clinical trials and research opportunities
The most common cancer in UK men. Active surveillance, hormone therapy, and now PSMA-targeted treatments are driving a rapidly evolving trial landscape.
The fourth most common cancer in the UK. Biomarker testing (MSI-H, BRAF, KRAS) increasingly determines trial eligibility, especially for immunotherapy approaches.
Prostate cancer trials often focus on treatment timing and sequencing. Colorectal cancer trials are more biomarker-driven with emphasis on molecular subtypes.
Search our database of 29,000+ UK clinical trials matched to your condition and profile
Browse Disease PathwaysData sourced from ClinicalTrials.gov. Trial counts are approximate and updated regularly.
TrialConnect is a trading name of Clinical Vendor Compare Limited.
